Lumacip Plus Cream is a topical dermatological formulation containing Hydroquinone 4% w/w, Tretinoin 0.05% w/w, and Fluocinolone acetonide 0.01% w/w, indicated for the treatment of hyperpigmentation disorders such as melasma, post-inflammatory hyperpigmentation, and other pigmentary abnormalities. Hydroquinone acts as a depigmenting agent by inhibiting tyrosinase, thereby reducing melanin synthesis and promoting skin lightening. Tretinoin, a retinoid, facilitates increased epidermal turnover and enhances the penetration of hydroquinone while also exerting anti-aging and keratolytic effects. Fluocinolone acetonide, a mild corticosteroid, helps to mitigate inflammation and irritation commonly associated with hydroquinone and tretinoin use, improving patient tolerance and adherence to therapy. Lumacip Plus Cream should be applied once daily at bedtime to clean, dry skin, avoiding contact with eyes and mucous membranes. It is recommended for short-term use under medical supervision due to potential side effects such as skin irritation, erythema, and increased photosensitivity. Patients should use sunscreen and limit sun exposure during treatment. This combination therapy offers a synergistic approach to managing hyperpigmentation by targeting melanin production, promoting skin renewal, and controlling inflammation, resulting in improved skin tone and texture.